Iovance Biotherapeutics Inc
NASDAQ:IOVA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Iovance Biotherapeutics Inc
NASDAQ:IOVA
|
US |
|
C
|
China Resources Land Ltd
F:CHZ
|
HK |
|
FirstEnergy Corp
NYSE:FE
|
US |
|
Concord Acquisition Corp III
NYSE:GCTS
|
US |
|
B
|
Ball Corp
F:BL8
|
US |
|
Seven & i Holdings Co Ltd
TSE:3382
|
JP |
|
Kellogg Co
NYSE:K
|
US |
|
K
|
Kawasaki Heavy Industries Ltd
XMUN:KHE
|
JP |
|
Kronos Worldwide Inc
NYSE:KRO
|
US |
|
E
|
Epizyme Inc
F:EPE
|
US |
|
Inchcape PLC
LSE:INCH
|
UK |
|
Futaba Industrial Co Ltd
TSE:7241
|
JP |
|
J
|
JD.Com Inc
DUS:013C
|
CN |
Wall St Price Targets
IOVA Price Targets Summary
Iovance Biotherapeutics Inc
According to Wall Street analysts, the average 1-year price target for
IOVA is 8.98 USD with a low forecast of 4.04 USD and a high forecast of 14.7 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is IOVA's stock price target?
Price Target
8.98
USD
According to Wall Street analysts, the average 1-year price target for
IOVA is 8.98 USD with a low forecast of 4.04 USD and a high forecast of 14.7 USD.
What is the Revenue forecast for Iovance Biotherapeutics Inc?
Projected CAGR
29%
The compound annual growth rate for Revenue over the next 8 years is 29%.
What is the Gross Profit forecast for Iovance Biotherapeutics Inc?
Projected CAGR
43%
The compound annual growth rate for Gross Profit over the next 8 years is 43%.